ADIM
SYNA icon

Alpha DNA Investment Management’s Synaptics SYNA Stock Holding History

Alpha DNA Investment Management’s Portfolio SYNA Stock Details SYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,526
Closed -$1.1M – 167
2022
Q1 		$1.1M Buy
5,526
+34
+0.6% +$7.54K 0.77% 103
2021
Q4 		$1.59M Buy
+5,492
New +$1.31M 1% 43
2021
Q2 		– Sell
-5,114
Closed -$692K – 583
2021
Q1 		$692K Sell
5,114
-2,951
-37% -$359K 0.8% 37
2020
Q4 		$777K Buy
+8,065
New +$657K 0.83% 46

Other funds holding SYNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha DNA Investment Management's SYNA Position: Q2 2022 in Review

Alpha DNA Investment Management sold out of Synaptics (SYNA) in Q2 2022, closing a stake of 5,526 shares — an estimated $1.1M sold.

Alpha DNA Investment Management first reported a position in SYNA in Q4 2020 and held it in 4 quarters. The position peaked at $1.59M in Q4 2021. 319 funds tracked by Wall St. Rank hold SYNA as of Q2 2022.

  • Alpha DNA Investment Management reported no remaining Synaptics position as of Q2 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 5,526 Synaptics shares in Q2 2022, an estimated $1.1M.
  • Alpha DNA Investment Management first reported a position in Synaptics in Q4 2020 and held it in 4 quarters.
  • Alpha DNA Investment Management's Synaptics position peaked at $1.59M in Q4 2021.
  • 319 funds tracked by Wall St. Rank held Synaptics as of Q2 2022.

Based on Alpha DNA Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.